Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Oct 28, 2013
Company News

Depomed, PDL BioPharma deal

BioCentury | Oct 28, 2013
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Oct 21, 2013
Top Story

PDL buys Depomed's diabetes royalty stream

BioCentury | May 7, 2013
Financial News

Santarus' 1Q13 earnings beat Street

BioCentury | Sep 19, 2011
Analyst Picks & Changes

Analyst picks & changes

BioCentury | Aug 29, 2011
Company News

Depomed, Santarus deal

BioCentury | Aug 29, 2011
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
BioCentury | Aug 22, 2011
Company News

Depomed, Santarus expand Glumetza deal

Items per page:
1 - 10 of 57